Yisheng Pharmaceutical Co., Ltd.
益盛药业
002566
Shenzhen Stock Exchange
Key Financials
Announcements
Legal Opinion from Beijing Zhide Law Firm Regarding the 2025 Annual Shareholders' Meeting of Jilin Province Jianshan Yisheng Pharmaceutical Co., Ltd.
Announcement of the 2025 Annual Shareholders' Meeting Resolutions
Announcement on Participating in the 2026 Online Collective Reception Day for Investors of Listed Companies in Jilin Region
Announcement on the Completion of Business Registration Changes by the Controlling Subsidiary
Q1 2026 Report
Progress Announcement on the Use of Idle Own Funds to Purchase Wealth Management Products
Announcement on the reappointment of the audit institution for the year 2026
2025 Annual Work Report of the Board of Directors
Independent Director's 2025 Annual Report (Chen Qibin)
Independent Director's 2025 Annual Report (Li Ming)
Independent Director's 2025 Annual Report (Liu Chaoyang)
Independent Director's 2025 Annual Report (Sun Lirong)
Announcement on holding the 2025 online performance briefing
2025 Internal Control Audit Report
2025 Internal Control Evaluation Report
Company's articles of association
Announcement on the remuneration plan for directors and senior management
Announcement on changing the company's business scope and amending the articles of association
Notice from Jilin Province Jianshan Yisheng Pharmaceutical Co., Ltd. on the convening of the 2025 Annual Shareholders' Meeting
Announcement of the resolution from the sixth meeting of the ninth board of directors
Announcement on the profit distribution plan for the year 2025 from Jilin Province Jianshan Yisheng Pharmaceutical Co., Ltd.
Evaluation report on the performance of the accounting firm by the company for the year 2025
Report from the Audit Committee of the Board on the performance of supervisory duties by the accounting firm for the year 2025
Special audit report on the summary table of non-operating fund occupation and other related party transactions for the year 2025
Summary table of non-operating fund occupation and other related party transactions
Special opinion on the board's assessment of the independence of independent directors
2025 Annual Audit Report
2025 Annual Report
Summary of the 2025 Annual Report
Announcement on the use of idle self-owned funds to purchase financial products
Notes & Comments
Sign in to leave a comment or private note.
Loading…